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Single Particle and PET-based 
Platform for Identifying Optimal 
Plasmonic Nano-Heaters for 
Photothermal Cancer Therapy
Jesper Tranekjær Jørgensen1,*, Kamilla Norregaard1,2,*, Pengfei Tian2,3, Poul Martin Bendix2, 
Andreas Kjaer1 & Lene B. Oddershede2
Plasmonic nanoparticle-based photothermal cancer therapy is a promising new tool to inflict localized 
and irreversible damage to tumor tissue by hyperthermia, without harming surrounding healthy 
tissue. We developed a single particle and positron emission tomography (PET)-based platform 
to quantitatively correlate the heat generation of plasmonic nanoparticles with their potential as 
cancer killing agents. In vitro, the heat generation and absorption cross-section of single irradiated 
nanoparticles were quantified using a temperature sensitive lipid-based assay and compared to their 
theoretically predicted photo-absorption. In vivo, the heat generation of irradiated nanoparticles 
was evaluated in human tumor xenografts in mice using 2-deoxy-2-[F-18]fluoro-D-glucose (18F-FDG) 
PET imaging. To validate the use of this platform, we quantified the photothermal efficiency of near 
infrared resonant silica-gold nanoshells (AuNSs) and benchmarked this against the heating of colloidal 
spherical, solid gold nanoparticles (AuNPs). As expected, both in vitro and in vivo the heat generation 
of the resonant AuNSs performed superior compared to the non-resonant AuNPs. Furthermore, 
the results showed that PET imaging could be reliably used to monitor early treatment response 
of photothermal treatment. This multidisciplinary approach provides a much needed platform to 
benchmark the emerging plethora of novel plasmonic nanoparticles for their potential for photothermal 
cancer therapy.
Photothermal therapy, which involves the application of plasmonic nanoparticles as light-triggered thermal 
transducers1–5, has emerged as a promising cancer treatment strategy within the last decade6–9, and much effort is 
being put into developing the most efficient light-to-heat converters10–15. The temperatures generated upon laser 
irradiation of plasmonic nanoparticles are so extreme16 that nearby cancer cells immediately ablate or become 
irreversibly damaged; meanwhile the heating is sufficiently localized that surrounding tissue is left unharmed17–20. 
The strongly enhanced photoabsorption properties of plasmonic nanoparticles are a consequence of a phenome-
non known as surface plasmon resonance; the collective oscillations of the plasma electrons when resonant with 
the excitation light21. The absorption spectrum of a plasmonic nanoparticle can be tuned by changing the size, 
shape and composition of the nanoparticle12,22–25, and in particular near infrared (NIR) resonant nanoparticles are 
of interest for photothermal therapy due to the efficient penetration and low absorption of NIR light in tissue26. A 
second factor crucial for photothermal therapy is delivery of nanoparticles to the tumor. One of the great advan-
tages of nanomedicine for cancer therapy is that nano-sized drugs and particles, when injected into the blood-
stream, passively accumulate in tumor tissue through the leaky tumor vasculature27,28; a phenomenon known as 
the enhanced permeability and retention (EPR) effect. The EPR effect varies between tumor types29, but in general 
favors accumulation of sub-100 nm structures30. As a fraction of the nanoparticles will end up in healthy tissue 
after being injected intravenously, especially in the liver and spleen31,32, it is also important to consider the bio-
compatibility of the nanoparticles. For these reasons, focus has been put on identifying and developing plasmonic 
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nanoparticles which are efficient light-to-heat converters, are biocompatible, accumulate efficiently by the EPR 
effect, and ultimately can minimize or eliminate tumors in vivo. Gold nanostructures meet these requirements 
and provide easy surface chemistry for modifications with functional biomolecules3. Spherical, solid gold nano-
particles (AuNPs) are easily synthesized, but in the size range useful for EPR-based tumor delivery their plasmon 
resonance peaks are in the visible region; hence, they may not be optimal candidates for in vivo photothermal 
therapy19,24. Silica-gold nanoshells (AuNSs)33, composite structures with a silica core surrounded by a thin gold 
shell, were the pioneering plasmonic nanoparticles used for photothermal therapy6,7,34. The AuNSs show great 
photothermal efficacy at NIR wavelengths, however, a relatively large ratio of scattering to absorption efficiency35, 
as well as diameters > 100 nm which limit the EPR-based tumor delivery, somewhat lower their potential in vivo. 
Gold nanorods, which have efficient longitudinal mode absorption in the NIR even at sub-100 nm dimensions, 
have also been put forward as efficient light-to-heat converters and as candidates for photothermal therapy24,36,37. 
However, their potential is limited by their synthesis that involves high concentrations of cytotoxic surfactants 
that are difficult to remove entirely. Furthermore, nanorods are only efficient light-to-heat converters if they 
are aligned with the polarization vector of the irradiating laser light, and they have been shown to restructure 
into non-resonant shapes upon irradiation, even at relatively low intensities38. In recent years, new generations 
of multi-layered structures such as the nanomatryoshkas15,39, as well as more exotic shapes such as nanohexa-
pods12,14, nanocages9,40 or nano-raspberries10 have been developed with the aim of optimizing NIR absorption 
efficiencies and having dimensions relevant for tumor retention via the EPR effect.
It has proved non-trivial to directly measure or theoretically predict the thermal response of irradiated nan-
oparticles, this is mainly because the light intensity and other physical parameters at the position of the nano-
particle are not known and the particle might disintegrate or change shape38 upon irradiation. Moreover, the 
understanding of how nanoparticles interact with electromagnetic radiation is not complete. Therefore, as addi-
tional types of optimized plasmonic nanoparticles are continuously being developed there is an urgent need for 
efficient strategies to quantify and compare their light-to-heat converting capabilities, and thereby their potential 
for photothermal cancer therapy.
Here, the heat generation of NIR-absorbing AuNSs was benchmarked against AuNPs that mainly absorb light 
in the visible region. In vitro, the nanoparticles were compared on a single particle level using an assay based on 
a temperature-sensitive biological matrix that allowed for a direct quantification of both the temperature profile 
of a single NIR irradiated nanoparticle and its absorption cross-section which can be used to predict the ability 
of the particle to heat macroscopic environments. To our knowledge, this is the first quantitative assessment of 
the temperature profile of a NIR irradiated single AuNS. In vivo, the nanoparticles were injected directly into 
subcutaneous human tumor xenografts in mice and the photothermal effect of the nanoparticles was quantified 
by PET imaging with a 18F-labelled glucose analogue, 18F-FDG. This provided a quantitative measure of decreased 
tumor metabolism in treated areas as early as an hour after treatment. The results of our in vitro evaluation of the 
nanoparticles are consistent with their in vivo therapeutic effect and we here demonstrate a strategy that can be 
reliably used to screen and evaluate the potential of any nanoparticle for photothermal treatment.
Results
Photo-absorption of plasmonic nanoparticles. For this study we chose to compare nanoparticles with 
potential for photothermal cancer therapy using the criteria that the particles should be commercially available 
in a highly homogeneous quality, they should be biocompatible, and they should not restructure upon NIR irra-
diation. To probe the sensitivity of our methods, both nanoparticles resonant with NIR light and nanoparticles 
non-resonant with NIR light were tested. As a NIR resonant nanoparticle we selected AuNSs with a total diam-
eter of 150 nm (core diameter = 120 nm, shell thickness = 15 nm, see Fig. 1a). These dimensions provide a peak 
absorption at 799 nm which overlaps well with the laser wavelengths used (807 nm for the in vivo experiments and 
1064 nm for the single particle in vitro experiments; see Fig. 1b). To compare to a NIR non-resonant nanoparticle, 
we selected spherical solid AuNPs with the same diameter (150 nm) and peak absorption at 614 nm (see Fig. 1). 
Importantly, the NIR resonant AuNSs are considered too big for efficient EPR mediated tumor accumulation, 
and reducing their dimensions would imply shifting their resonance33,41. Therefore, we included a AuNP with a 
dimension more compatible with EPR accumulation in the study, namely a AuNP with a diameter of 80 nm27,30. 
Notably, 80 nm AuNPs are not NIR resonant (their peak absorption is at 550 nm; see Fig. 1b).
To theoretically compare the absorption of the nanoparticles we calculated the absorption cross-sections using 
the Finite Element Method (FEM) (see Supplementary Fig. S1). The absorption cross-section is directly related 
to the light-to-heat conversion efficiency of a nanoparticle and is therefore a suitable comparative theoretical 
measure25,35,42. We found that at the wavelength of the laser used for the in vivo experiment (807 nm) the absorp-
tion cross-section of the AuNSs was nearly 6 times larger than that of the 150 nm AuNPs with the same particle 
diameter, at 1064 nm the difference was a factor of 3. Furthermore, the absorption cross-section, which increases 
with volume, but only in a linear fashion as long as the radius is smaller than the skin depth43, was found to be an 
order of magnitude smaller for the 80 nm AuNPs compared to that of the 150 nm AuNPs.
Quantifying single particle heating in vitro. To quantify the heat generation of a single irradiated nano-
particle in vitro we used the inverse relationship between the temperature increase of a nanoparticle, Δ T, and the 
distance, D, to the particle center described by the relation44:
∆ = .T D CI
D
( ) (1)
Here, C is a physical constant containing the thermal conductivity of water and glass, the particle radius and the 
absorption cross-section of the nanoparticle, and I is the intensity of the laser. If C can be extracted at one point 
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on the nanoparticle’s temperature profile, equation (1) can be used to map out the entire temperature profile and 
the temperature increase at any distance from the nanoparticle–center, including the surface temperature, can be 
inferred (see Fig. 2a)16,38,45.
To measure the temperature at some distance from the irradiated nanoparticle we used an assay based on the 
well-characterized gel-to-fluid phase transition of a 2D phospholipid (DC15PC) bilayer (see Fig. 2b). Detection 
of the local heating around the irradiated nanoparticle was facilitated by incorporating fluorescent molecules 
with phase sensitive lipid anchors in the supported lipid bilayer16,25,38. A tightly focused Gaussian 1064 nm laser 
beam was used to irradiate a nanoparticle embedded in the bilayer that immediately induced local melting when 
Figure 1. Characteristics of the plasmonic nanoparticles. (a) Sketch of the investigated plasmonic 
nanoparticles. (b) Absorption spectra in water for the three investigated nanoparticle types show that AuNPs 
with diameters of 80 nm and 150 nm exhibit resonances in the visible region (400–700 nm), whereas the AuNSs 
(diameter 150 nm) have their resonance peak in the near infrared region (700–1100 nm).
Figure 2. Measuring single particle heat generation using a 2D phospholipid bilayer assay. (a) The 
temperature profile of an irradiated AuNS (diameter 150 nm) at the laser intensity P = 2.7 × 106 W/cm2. The 
temperature decays with increasing distance from the particle center. (b) The biological assay used to map 
out the temperature profile. The assay consists of a 2D phospholipid bilayer with a well-characterized phase 
transition and a fluorescent molecule that senses the phase and preferentially partitions into the fluid phase. 
The surface temperature of the nanoparticle can be extracted by determining one point on the temperature 
profile, ΔT, in this assay corresponding to half the diameter of the melted footprint, Dm. (c) Optically heating 
a nanoparticle embedded in the bilayer with a tightly focused laser beam induces local melting. Here is shown 
representative melted footprints for all three nanoparticles at the same laser intensity, P = 4.3 × 106 W/cm2. The 
fluorescent images are recorded by acquiring an emission bandwidth of 496 nm–587 nm and the nanoparticles 
are imaged by recording 594 nm laser light reflected from the nanoparticle. Scale bars are 2 μ m. (d) The surface 
temperature as a function of laser intensity for all three nanoparticles derived from the size of the melted 
footprints and using equation (1). n = 12 for all datasets and error bars represent one standard deviation (SD).
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the temperature exceeded the melting transition, Tm = 33.8 °C, of the bilayer25. Upon melting, the phase sensitive 
fluorescent molecules partitioned into the melted region producing a fluorescent footprint. In Fig. 2c, represent-
ative images of the melted footprints for all three nanoparticles at the same laser intensity are shown. The melted 
footprints are clearly seen as bright fluorescent circles centered at the position of the nanoparticle, the largest 
footprint was induced by the AuNSs and the smallest by the 80 nm AuNPs. The radial size, Dm, of the melted 
footprints increased with laser intensity (see Supplementary Fig. S2) while for all the individual laser intensities 
the temperature at the phase boundary equaled Tm which allowed calculation of the constant, C, in equation (1).
By inserting the experimental value for C and the radius of the nanoparticles in equation (1), the surface 
temperature as a function of laser intensity was found for all three nanoparticles, see Fig. 2d. The surface tem-
peratures of all three nanoparticles increased linearly with laser power as predicted by equation (1), though, for 
the highest laser intensity used to irradiate the AuNSs, the temperature increase saturated around 240 °C. This 
temperature saturation is in accordance with reported observations of temperature profiles of irradiated metallic 
nanoparticles16,46 suggesting that a temperature induced phenomenon, possibly micro-bubble generation, may 
kick in at the surface of continuous wave irradiated nanoparticles reaching temperatures beyond 240 °C. Another 
possibility could be that the AuNSs disintegrate upon extensive heating, however, if we reheated AuNSs after 
allowing the bilayer to equilibrate to gel phase, it was in most cases possible to induce a melting footprint once 
more, thus indicating that the AuNSs are still able to heat its surroundings and probably were not damaged (see 
Supplementary Fig. S3). While the temperature increase of the AuNPs, in agreement with literature, increases 
with particle size16,45, the heat generation of the AuNSs was substantially higher than of any of the AuNPs at all 
laser intensities. The heat conversion efficiency for each nanoparticle can be derived from linear fits to the data in 
Fig. 2d, yielding (1412 ± 800.8) K/W for the AuNSs, (573.7 ± 33) K/W for 150 nm AuNPs, and (492.3 ± 80) K/W 
for the 80 nm AuNPs (errors given by the 95% confidence interval).
While the single particle surface temperatures are of interest for some applications, we note that particle sur-
face temperatures alone cannot be used for predicting the bulk heating efficiency of different types of nanoparti-
cles, as this depends on the geometry of the nanoparticles in the solution47 and on the nanoparticles’ absorption 
cross-section. Our assay provides an experimental quantification of the absorption cross-section by using the 
following equation47
pi
=
∆C T kR
I
4 , (2)abs
P
where Δ TP is the nanoparticle’s surface temperature, k is the heat conductivity of the combined glass and water 
system at 300 K which we approximate to be a simple average of kglass = 1.1 W/m K48 and kwater = 0.61 W/m K as 
suggested in ref. 47, I is the laser intensity and R is the particle radius. Using equation (2) we get Cabs = (5781 ± 711) 
nm2 for a AuNS, ( 1332 ± 399) nm2 for a 150 nm AuNP, and (390 ± 138) nm2 for a 80 nm AuNP. These numbers 
can be compared to the theoretical values which can be obtained from Supplementary Fig. S1: 2990 nm2 for a 
AuNS, 984 nm2 for a 150 nm AuNP and 98 nm2 for a 80 nm AuNP. The experimental values are found to be higher 
than the theoretically calculated values even when including the uncertainties. This discrepancy between theory 
and experiments may originate from uncertainties in determining the laser intensity at the position of the nano-
particle as well as uncertainties in determining the combined heat conductivity of the water-glass system experi-
enced by a particle which has a point contact with the glass, but is immersed in the water.
Quantifying bulk heating in vitro. To analyze the heating capabilities of the nanoparticles in bulk, we 
irradiated aqueous solutions of the nanoparticles with the 807 nm diode laser and measured the bulk temperature 
using thermographic imaging every 15 seconds (see sketch in Fig. 3a). First, we prepared nanoparticle solutions 
of 5 × 1010 nanoparticles/mL (same concentration was used for all nanoparticle types). The maximum tempera-
ture in the solution for each laser intensity is shown in Fig. 3b.
The temperature in the AuNS solution rapidly increased and exceeded 100 °C at a laser intensity of P ~2 W/cm2, 
the 150 nm AuNP solution reached 100 °C at a laser intensity of P ~4 W/cm2, and the 80 nm AuNP solution 
only reached ~80 °C for the highest laser intensity used. The saline solution only heated slightly, reaching a 
Figure 3. Thermographic assessment of the heat generation in vitro. (a) Illustration of the assay using 
thermographic imaging to assess the laser mediated bulk heating. (b,c) Plots of the maximum absolute 
temperature in aqueous bulk solutions as a function of laser intensity measured in (b) 5 × 1010 nanoparticle/mL 
solutions or (c) 5 × 108 nanoparticle/mL solutions of AuNSs (blue circle), 80 nm AuNPs (red diamonds), 150 nm 
AuNPs (yellow squares), and saline (grey stars). The laser intensity was 0.58 W/cm2.
www.nature.com/scientificreports/
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temperature increase of Δ T~10 °C for the highest laser intensity used. To investigate the effect of the nanoparticle 
concentration, we repeated the experiment in 100-fold dilutions (see Fig. 3c). Here, we only observed a temper-
ature increase distinct from the saline sample in the AuNS solution; however, it was significantly smaller than 
observed in the high concentration sample. These concentration-dependent observations are in agreement with 
findings in literature35,49.
Evaluating the photothermal treatment response in vivo. 18F-FDG PET imaging of mice bearing 
subcutaneous human neuroendocrine lung carcinoid (H727) tumor xenografts was used to compare the photo-
thermal effect of the nanoparticles in vivo. When the tumor volume reached ~700 mm3 the animals were divided 
into four groups receiving the same number of nanoparticles of the various types tested (50 μ L of 5 × 1010 nano-
particles/mL of 80 nm AuNPs, 150 nm AuNPs, AuNSs). In addition, we also had a control group receiving 50 μL 
of saline (n = 6, each group). As we in this study focused on the heat-conversion efficiencies of the different 
nanoparticles it was important to have a fixed number of nanoparticles in the tumor. To obtain this, the same 
concentration of nanoparticles was delivered by intratumoral injection in all experiments. Immediately after the 
injection, the mice were irradiated with the diode laser (807 nm) for 5 minutes at the tumor region with a laser 
intensity of 0.58 W/cm2. In addition, control groups of sham treated mice receiving nanoparticles but no irradi-
ation were included (n = 3, each group). Thermographic imaging every 15 s was used to assess the temperature 
increase at the surface of tumor xenografts in the different treatment groups while they were irradiated and all 
mice were 18F-FDG PET scanned one day prior to the treatment (Baseline), an hour after (Day 0) and at 2 days 
(Day 2) after laser irradiation.
Figure 4a shows representative coronal images of the whole-body 18F-FDG uptake in mice from the four 
treatment groups at Baseline, Day 0, and Day 2 scan. By visual inspection of the PET images it was evident 
that mice from the AuNS group generally had a subvolume in the treated tumor area with low or no uptake of 
18F-FDG, both immediately and two days after treatment. The same was also the case for some mice in the 150 nm 
AuNP group, while other showed no clear visual effect. Contrary, no changes in 18F-FDG uptake over time were 
observed in mice from the 80 nm AuNP and saline groups. The signal loss occurring post-treatment is a strong 
marker that the cancer cells in this region have reduced metabolism or are ablated as a consequence of the treat-
ment (region is marked by red arrows in Fig. 4a). No visual change in 18F-FDG tumor uptake was observed in any 
of the sham treated animals as a result of nanoparticle administration (See Supplementary Fig. S4).
To quantify 18F-FDG accumulation we defined regions of interest (ROIs) on whole tumor regions and 
extracted the uptake as percent of injected dose per grams of body weight (%ID/g). The different treatment 
groups had comparable mean and maximum tumor uptake of 18F-FDG (see Supplementary Fig. S5). However, 
from the PET images it was clear that the treatment was limited to a rather small tumor subvolume. Therefore, 
mean and maximum 18F-FDG uptake that is commonly used for treatment response evaluation, is inexpedient for 
quantifying the effect of heating in this setup. Instead, to quantify the tumor volume with low or no uptake of 
18F-FDG, we determined the tumor volume in which the intensity was lower than the mean of the distribution of 
%ID/g minus 3/2 of the standard deviations. This volume is denoted Vlow
FDG and will increase after laser irradiation 
if the treatment generates sufficient heat to damage cancer cells. As the size of Vlow
FDG can be influenced by other 
factors, especially the degree of tumor necrosis, each individual data set was normalized to the value from the 
baseline scan in order to assess the relative change after treatment. In Fig. 4b,c the mean and individual relative 
changes in Vlow
FDG is shown for each group. After treatment, the mean Vlow
FDG in the AuNS group increased signifi-
cantly over time and the relative change was also significantly larger than in all other groups both at Day 0 and 
Day 2, (p value < 0.005 on Day 0 and p value < 0.0001 on Day 2 compared to Vlow
FDG of the other groups). Contrary, 
the relative changes in mean Vlow
FDG of the 80 and 150 nm AuNP groups were not significantly different from the 
saline group on either Day 0 or Day 2. When looking at individual animals in the AuNS group, five animals had 
an increase in Vlow
FDG after treatment, while one mouse showed an unaltered volume comparable to animals in the 
saline group. In the 150 nm AuNP group only some of the mice had a treatment response, overall leading to a 
small but significant mean increase in Vlow
FDG after treatment. No change in Vlow
FDG was observed over time in the 
80 nm AuNP experiments nor in the saline group or in the sham treated animals (see Supplementary Fig. S6), 
confirming that a combination of nanoparticle injection and irradiation is required to induce a change in 18F-FDG 
tumor uptake.
Further, thermographic imaging (see Fig. 4d; n = 3, each group) showed that the maximum temperature at the 
surface of the AuNS laden tumors increased rapidly upon laser irradiation where after it reached a plateau (~after 
3 min) with a maximum temperature of 51.7 ± 3.4 °C. In the other three groups the temperature of the tumor area 
increased more slowly throughout the entire duration of laser irradiation. The highest temperature measured was 
(42.4 ± 1.7) °C in the 80 nm AuNP group, (44.7 ± 1.7) °C in the 150 nm AuNP group, and (40.2 ± 2.4) °C in the 
saline group. These measurements support the findings from the PET-based evaluation, and are a clear indication 
that higher temperatures were reached in the mice receiving AuNSs compared to the other groups.
Discussion
In recent years much effort has been devoted to developing new nanoparticles for photothermal cancer therapy. 
There are different factors that determine their potential; e.g., their capabilities as light-to-heat converters when 
irradiated with laser light capable of penetrating tissue, their tumor accumulation, and their stability and toxic-
ity. As different experimental conditions affect treatment outcome, it is often difficult to compare nanoparticles 
between studies in literature. Here we used different methods to compare the heat generation of nanoparticles for 
photothermal cancer therapy.
At the single particle level our theoretical FEM calculations (Supplementary Fig. S1) and in vitro direct meas-
urement allowed us to assess the particle temperature (Fig. 2d) and the absorption cross-section. As expected, the 
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resonant AuNSs performed substantially better as photothermal heat transducers if irradiated by NIR light com-
pared to the non-resonant AuNPs. Interestingly, the temperature differences between the nanoparticles meas-
ured in bulk were even more significant as shown in Fig. 3d. This is explained by the fact that the AuNSs have 
a significantly larger absorption cross-section than the AuNPs. This effect is also clearly observed in Fig. 2c and 
Supplementary Fig. S2 where the larger nanoparticles, with the highest absorption cross-section, produce signif-
icantly greater melted footprints compared to the 80 nm AuNPs. Limitations to the in vitro setup relates to when 
the extent of the melted footprint is so small that it is comparable with the diffraction limit of the imaging laser 
light (λ = 488 nm), leading to slightly overestimated surface temperatures (see footprints of the 80 nm AuNPs in 
Fig. 2d and Supplementary Fig. S2). Also, the small melted footprints for this nanoparticle size are mostly con-
fined within the NIR laser focus and additional background heating on the order of 1K is expected to occur50.
In vivo, PET imaging of tumor uptake of 18F-FDG was used to compare the effect of heating in nanoparticle- 
laden subcutaneous human tumor xenografts in mice (Fig. 4), and the results agreed with the findings from the 
in vitro assays. In the field of nanoparticle-mediated photothermal cancer therapy, PET has mainly been used to 
track and localize radiolabeled nanoparticles51,52. However, PET imaging also holds a great potential for early 
evaluation of treatment response and can potentially improve treatment outcome, as well as reduce the time and 
cost. 18F-FDG, the most widely used PET tracer in oncology, has been particularly successful due to tumor cells’ 
increased glucose metabolism, and it has been used clinically for both tumor diagnosing and evaluation of treat-
ment response53,54. 18F-FDG PET imaging has previously also been applied to quantify the effect of photothermal 
cancer therapy in a few preclinical studies9,12 and overall our results support the use of 18F-FDG PET as a reliable 
and fast evaluation tool for the treatment effect of nanoparticle-based photothermal cancer therapy. Limitations 
to the in vivo setup include variations in the deposition of the nanoparticles during intratumoral injection, 
Figure 4. PET evaluation of the treatment response. (a) Images showing the coronal planes of the 18F-FDG 
PET scan of mice from each nanoparticle group (columns). The rows show the baseline PET scan, the scan 
immediately after the laser irradiation (Day 0), and the scan two days post-treatment (Day 2). White arrows 
mark the tumor location where the nanoparticles were administered and subsequently irradiated with the 
807 nm laser (laser intensity of 0.58 W/cm2). In the mice from the AuNS and 150 nm AuNP groups there is a 
tumor subvolume with decreased uptake of 18F-FDG (marked by red arrows) both at Day 0 and Day 2. (b,c) 
Vlow
FDG at different timepoints. If the treatment is effective this volume will increase after laser irradiation. Each 
individual data set has been normalized to the baseline value. The mean relative changes in the tumor volume 
with low 18F-FDG uptake in the four treatment groups are shown in (b) and for individual animals in (c) (red: 
80 nm AuNP, yellow: 150 nm AuNP, blue: 150 nm AuNS, and grey: saline). n = 6, each group. (d) Plots of the 
temperature evolution measured using thermographic imaging at the skin surface of the tumors of mice 
receiving AuNSs (blue circle, n = 3), 80 nm AuNP (red diamonds, n = 3), 150 nm AuNP (yellow squares, n = 3), 
and saline (grey stars, n = 7). The laser intensity was 0.58 W/cm2. Error bars represent one SD. * denotes p 
value < 0.05, * * denotes p value < 0.01, and * * * * denotes p value < 0.0001.
www.nature.com/scientificreports/
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which can affect the effect of heating. Small differences in the depth of the intratumoral injection and back leakage 
of nanoparticles due to high interstitial pressure are likely to have caused some of the variation observed in the 
treatment response within each group. Finally, because necrotic tissue has no 18F-FDG uptake, the degree of 
necrosis within a tumor can affect the size of Vlow
FDG. Therefore, it is important that the tumor size within each 
group is matched.
In summary, the in vitro screening assay has the great advantage that it is fast and easy to perform and reliably 
pinpoints which nanoparticles have potential for photothermal therapy. This screening can be performed before 
selecting and optimizing nanoparticles for in vivo conditions and introducing the nanoparticles into animal mod-
els, thereby reducing the number of animals needed for the in vivo evaluation. However, although the in vitro 
assay reliably pinpoints which nanoparticles are most efficient light-to-heat converters, there are other factors 
in a biological context that are not accounted for in an in vitro system, e.g., delivery efficiency, particle-coupling 
effects11,55,56, or particle disintegration. Hence, the in vitro assay cannot stand alone and should be accompanied 
by in vivo evaluation of treatment response. Our results from photothermal therapy of tumor-bearing mice shows 
that PET imaging can provide a quantitative measure of how efficient different nanoparticles are at killing cancer 
cells. This is achievable on a time-scale of hours after treatment where standard evaluation methods based on 
morphological changes cannot yet detect any treatment response. We propose to use the presented strategy to 
assess and improve the potential for photothermal therapy of any type of nanostructure, while reducing time, 
cost, and number of animals. It is our hope that these methods will be systematically used as a platform for effi-
cient testing of the plethora of new emerging plasmonic nanoparticles being developed for photothermal cancer 
therapy.
Methods
Physical properties of the nanoparticles. The AuNSs (NanoComposix, USA) consisted of a 
119.7 ± 8.9 nm dielectric silica core surrounded by a thin gold shell (total diameter of 151.3 nm ± 7.7 nm; meas-
ured by supplier using transmission electron microscopy (TEM)). The AuNPs were spherical solid gold nanopar-
ticles with diameters of 150 nm (Nanopartz, USA; diameter: 150 nm ± 6 nm measured by supplier using TEM) 
and of 80 nm (NanoComposix USA; diameter: 81.7 nm ± 11.4 nm measured by supplier using TEM). All nano-
particles were obtained functionalized with 5 kDa poly(ethylene glycol) (PEG). Upon arrival, the UV-vis spectra 
of the nanoparticles were measured in aqueous solutions using spectrophotometry (Fig. 2b) and the hydrody-
namic diameters and zeta-potentials were measured using Zetasizer Nano Series (Supplementary Table 1). The 
theoretical absorption cross-sections were calculated by building a 3D simulation model using COMSOL multi-
physics, which is a commercially available FEM package (see Supplementary Methods and Supplementary Fig. 1).
In vitro 2D heating assay. The phospholipid bilayer was prepared by mixing 2 μ moles of saturated lipids 
(1,2-dipentadecanyol-sn-glycero-3-phosphicholine), with 1 mole% of 3,3′ -dilinoleyloxacarbocyanine perchlo-
rate (FAST-DiO) fluorophores and chloroform. In a clean vial, a thin film of the lipid-dye mixture was carefully 
evaporated under nitrogen flow and left in vacuum for 2 hours. 1 mL of preheated 150 mM NaCl PBS buffer was 
added to hydrate the lipid-dye film and left for 1 hour at 37 °C. After hydration, the mixture was extruded through 
polycarbonate filters with 50 nm pore size to create small unilamellar vesicles. To create a highly hydrophilic glass 
surface to support the lipid bilayer, clean glass slides were O2 plasma cleaned for at least 30 min. A sample cham-
ber was constructed and 200 μ L of the extruded unilamellar vesicles were added to fuse with the glass surface and 
incubated for 2 hours at 37 °C. Excess vesicles were removed by thoroughly washing the supported phospholipid 
bilayer with milliQ water preheated to ~50 °C. Nanoparticles suspended in milliQ water were added and allowed 
to adhere to the bilayer. Only nanoparticles that were stuck to the bilayer were used for experiments.
The experiments were conducted on a Leica SP5 confocal microscope equipped with a piezoelectric stage into 
which an optical trap based on a 1064 nm tightly focused Gaussian beam was implemented (see beam profile in 
Supplementary Fig. 7a)57. A 100 × 1.4 NA Leica apochromatic oil objective was used to focus the optical trap 
and for visualization. The nanoparticles were imaged in reflection mode (excited by λ = 594 nm). FAST-DiO was 
excited by λ = 488 nm and emission collected with a bandwidth from 496 nm to 587 nm. The ambient temperature 
in the sample chamber was kept constant by using a thermostated stage and was measured to be Tambient = 26.7 °C 
by inserting a temperature probe into the chamber after the experiments. This value was used for the data analysis 
of the in vitro experiments.
Image analysis in the in vitro study. Images were analyzed in Matlab. The size of the individual melting 
footprint centered around the nanoparticle equals the distance from the particle center (which was located 
in every image by a centroid algorithm) to the location of the melting transition (Dm) where the temperature 
was Tm(Dm) = 33.8 °C25. First, the symmetry of the melting footprints was exploited by performing a rotationally 
averaged radial intensity plot (averaged from 0 to 2π for every distance from the nanoparticle). Subsequently, 
Dm was quantified by applying a threshold, Tr, to the images to distinguish the melted zone, containing higher 
density of fluorophores, from the background which consisted of a gel phase bilayer with a lower density of 
fluorophores. The background was quantified as the average of a region of interest, ROIbg, selected several 
micrometers away from the melted zone and the threshold was defined to be the intensity value at which the 
intensity had dropped to 50% of the maximum value inside a region of interest of the melted region (ROImelted): 
= +


− 
 ( )( )Tr mean ROIROI mean ROI bgmax( )2melted bg . To find the temperature at the surface of the nanoparticle 
(Dp = R) we used equation (1) to relate the temperature elevations at the nanoparticle surface and at the boundary 
of the melting region: Δ T(Dp) = Δ T(Dm)Dm/Dp where Δ T(Dm), Dm and Dp were experimentally measured.
Thermographic assessment of the photothermal efficiency in bulk and in vivo. 500 μ L aqueous 
solutions of all nanoparticles were prepared in Eppendorf tubes (concentrations of 5 × 1010 nanoparticles/mL and 
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of 5 × 108 nanoparticles/mL). Each nanoparticle solution and saline solution were irradiated continuously from 
the side with the 807 nm diode laser (beam diameter: ~1 cm) while the laser intensity was increased every 5 min 
(in the interval from 0 W/cm2 to 9.2 W/cm2). Real-time imaging of the sample temperature was recorded with a 
FLIR NIR thermal camera every 15 s. The images were analyzed using FLIR tools software to infer the maximum 
temperature in the sample.
In addition, during the 5 min laser irradiation of the tumor bearing mice, real-time thermographs were also 
taken and analyzed following the same procedure as in the in vitro bulk measurements.
Animal model. All animal experiments have been approved by the Danish Animal Welfare Council, min-
istry of Justice. All methods and experiments were carried out in accordance with the approved guidelines. 
Upon arrival the mice were allowed to acclimatize for one week in the animal facility and had access to water 
and chow ad libitum. Human neuroendocrine lung carcinoid cell line H727 (ECCAC, Salibury, UK) were cul-
tured in standard medium (RPMI medium 1640 + GlutaMAX) supplemented with 10% fetal calf serum and 1% 
penicillin-streptomycin at 37 °C and in 5% CO2. Tumor xenografts were established by subcutaneous injection of 
~106 H727 cells, dissolved in 100 μ l growth medium mixed with 100 μ l matrigel, into the left flank of the 6 weeks 
old female NMRI nude mice. Tumor dimensions were measured with a caliper on a regular basis and the volume 
calculated as volume = ½(length × width2). When tumors reached ~700 mm3 animals were matched into four 
treatment groups based on their tumor volumes; 80 nm AuNPs: 698.5 mm3 (mean) ± 144.7 mm3 (± SD), 150 nm 
AuNPs: 673.4 mm3 ± 191.2 mm3, AuNSs: 699 mm3 ± 234.3 mm3, or saline: 683.2 mm3 ± 203.6 mm3, (n = 6, each 
group). Three sham treatment groups were included (AuNS sham: 503.8 mm3 ± 298.9 mm3, 150 nm AuNP sham: 
349.8 mm3 ± 142.7 mm3, and 80 nm AuNP sham: 375.6 mm3 ± 205.7 mm3) (n = 3, each group).
In vivo photothermal therapy. During treatment the animals were anesthetized by sevoflurane and their 
temperature kept stable. The mice were injected approximately 3 mm into the tumor with 50 μ l of 5 × 1010 nano-
particles/mL or 50 μ l saline using a programmable syringe pump with a flow rate of 5 μ l/min (1 ml syringe, 25G 
needle). After injection the needle was left in the tumor for 10 min to equalize pressure and prevent back flow 
of blood and nanoparticles. Immediately after, the mice were irradiated for 5 min with a laser power density 
of 0.58 W/cm2 with an 807 nm diode laser. This laser power was decided upon as it was the highest power we 
could use without inflicting burns and scab formations. The diode laser was collimated with a beam diameter of 
10.72 mm (see Supplementary Fig. 7b). Two days after the photothermal treatment, the mice were euthanized.
PET/CT imaging. The mice were PET scanned the day before (baseline), 1 h (Day 0), and two days (Day 2) 
after treatment. 18F-FDG was obtained at Department of Nuclear Medicine & PET, Rigshospitalet, Denmark. The 
animals were anesthetized by sevoflurane and their temperature kept stable. Mice were injected with ~10 MBq 
18F-FDG through a tail vein, and PET scanned for 10 min 1 hour post injection using a small animal PET scanner. 
The energy window of the emission scans was set to 350–650 KeV with a time resolution of 6 ns. Acquired datasets 
were stored in listmode, post processed into 128 × 144 × 95 sinograms, and reconstructed using maximum a 
posteriori (MAP) algorithm into 256 × 256 × 95 matrixes with a voxel size of 0.29 × 0.29 × 0.79 mm3 and a reso-
lution of 1.2 mm at center field of view. Emission data was corrected for dead time and decay. Each PET scan was 
followed by a CT scan. ROIs were drawn on whole tumor regions and uptake quantified as mean and maximum 
%ID/g. Moreover, a threshold of the mean tumor uptake minus 3/2 standard deviations was applied to quantify 
the tumor volume with low or no 18F-FDG accumulation in all PET images V( )low
FDG . Each individual data set was 
normalized to the baseline value and the relative change in this volume within each group calculated as 
mean ± SD.
Statistics. Groups in the in vivo experiments were compared using a two-way ANOVA with repeated meas-
ures and Tukey’s post hoc test. Statistical analysis was performed in GraphPad Prism 6 and P < 0.05 was consid-
ered as statistical significant in all analyses.
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